Online inquiry

IVTScrip™ mRNA-Human ATAD2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK25136MR)

This product GTTS-WK25136MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ATAD2 protein. This product can be used in Neural progenitor cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_014109.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 29028
UniProt ID Q6PL18
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ATAD2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK25136MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK19883MR IVTScrip™ mRNA-Human AKTIP, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA AKTIP
GTTS-WK3001MR IVTScrip™ mRNA-Human Intestinal Alkaline Phosphatase, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA Intestinal Alkaline Phosphatase
GTTS-WK7350MR IVTScrip™ mRNA-Human ACSM1, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ACSM1
GTTS-WK23356MR IVTScrip™ mRNA-Human ATG16L2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ATG16L2
GTTS-WK23719MR IVTScrip™ mRNA-Human APOBEC3A, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA APOBEC3A
GTTS-WK19893MR IVTScrip™ mRNA-Human ALDH16A1, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ALDH16A1
GTTS-WK6599MR IVTScrip™ mRNA-Human ALDH1, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ALDH1
GTTS-WK19610MR IVTScrip™ mRNA-Human ALDOC, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ALDOC
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW